199 related articles for article (PubMed ID: 1535177)
21. Are we all of one mind? Clinicians' and patients' opinions regarding the development of a service protocol for predictive testing for Huntington disease. Canadian Collaborative Study for Predictive Testing for Huntington Disease.
Copley TT; Wiggins S; Dufrasne S; Bloch M; Adam S; McKellin W; Hayden MR
Am J Med Genet; 1995 Jul; 58(1):59-69. PubMed ID: 7573158
[TBL] [Abstract][Full Text] [Related]
22. Predictive DNA-testing for Huntington's disease and reproductive decision making: a European collaborative study.
Evers-Kiebooms G; Nys K; Harper P; Zoeteweij M; Dürr A; Jacopini G; Yapijakis C; Simpson S
Eur J Hum Genet; 2002 Mar; 10(3):167-76. PubMed ID: 11973620
[TBL] [Abstract][Full Text] [Related]
23. Attitudes toward presymptomatic testing in Huntington disease.
Mastromauro C; Myers RH; Berkman B
Am J Med Genet; 1987 Feb; 26(2):271-82. PubMed ID: 2949611
[TBL] [Abstract][Full Text] [Related]
24. Protocol for genetic testing in Huntington disease: three years of experience in Minnesota.
Nance MA; Leroy BS; Orr HT; Parker T; Rich SS; Heston LL
Am J Med Genet; 1991 Sep; 40(4):518-22. PubMed ID: 1836107
[TBL] [Abstract][Full Text] [Related]
25. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
26. The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.
Wiggins S; Whyte P; Huggins M; Adam S; Theilmann J; Bloch M; Sheps SB; Schechter MT; Hayden MR
N Engl J Med; 1992 Nov; 327(20):1401-5. PubMed ID: 1406858
[TBL] [Abstract][Full Text] [Related]
27. Early testing for Huntington disease in children: pros and cons.
Toufexis M; Gieron-Korthals M
J Child Neurol; 2010 Apr; 25(4):482-4. PubMed ID: 19808987
[TBL] [Abstract][Full Text] [Related]
28. [Psychosocial consequences of presymptomatic genetic testing. A retrospective study of testing for Huntington disease].
Jakobsen LB; Malt U; Nilsson B; Rosenlund S; Heiberg A
Tidsskr Nor Laegeforen; 1999 May; 119(13):1913-6. PubMed ID: 10382341
[TBL] [Abstract][Full Text] [Related]
29. Genetic testing and mental health: the model of Huntington disease.
Williams JK; Schutte DL
Online J Issues Nurs; 2000; 5(3):3. PubMed ID: 11380269
[TBL] [Abstract][Full Text] [Related]
30. Predictive and pre-natal testing for Huntington Disease in Australia: results and challenges encountered during a 10-year period (1994-2003).
Tassicker RJ; Marshall PK; Liebeck TA; Keville MA; Singaram BM; Richards FH
Clin Genet; 2006 Dec; 70(6):480-9. PubMed ID: 17100992
[TBL] [Abstract][Full Text] [Related]
31. Intended use of predictive testing by those at risk for Huntington disease.
Meissen GJ; Berchek RL
Am J Med Genet; 1987 Feb; 26(2):283-93. PubMed ID: 2949612
[TBL] [Abstract][Full Text] [Related]
32. Exploration of the effects of predictive testing for Huntington disease on intimate relationships.
Quaid KA; Wesson MK
Am J Med Genet; 1995 May; 57(1):46-51. PubMed ID: 7645597
[TBL] [Abstract][Full Text] [Related]
33. Non-participation in predictive testing for Huntington's disease: individual decision-making, personality and avoidant behaviour in the family.
Decruyenaere M; Evers-Kiebooms G; Boogaerts A; Cloostermans T; Cassiman JJ; Demyttenaere K; Dom R; Fryns JP; Van den Berghe H
Eur J Hum Genet; 1997; 5(6):351-63. PubMed ID: 9450179
[TBL] [Abstract][Full Text] [Related]
34. "You're one of us now": young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP).
Duncan RE; Gillam L; Savulescu J; Williamson R; Rogers JG; Delatycki MB
Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):47-55. PubMed ID: 18189288
[TBL] [Abstract][Full Text] [Related]
35. Partners of mutation-carriers for Huntington's disease: forgotten persons?
Decruyenaere M; Evers-Kiebooms G; Boogaerts A; Demyttenaere K; Dom R; Fryns JP
Eur J Hum Genet; 2005 Sep; 13(9):1077-85. PubMed ID: 15999117
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for suicide in Huntingtons disease: a retrospective case controlled study.
Lipe H; Schultz A; Bird TD
Am J Med Genet; 1993 Dec; 48(4):231-3. PubMed ID: 8135306
[TBL] [Abstract][Full Text] [Related]
37. Psychiatric morbidity associated with early clinical diagnosis of Huntington disease in a predictive testing program.
Lam RW; Bloch M; Jones BD; Marcus AM; Fox S; Amman W; Hayden MR
J Clin Psychiatry; 1988 Nov; 49(11):444-7. PubMed ID: 2972696
[TBL] [Abstract][Full Text] [Related]
38. Understanding the decision to take the predictive test for Huntington disease.
Meissen GJ; Mastromauro CA; Kiely DK; McNamara DS; Myers RH
Am J Med Genet; 1991 Jun; 39(4):404-10. PubMed ID: 1678928
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
40. Experience over fifteen years with a protocol for predictive testing for Huntington disease.
Dufrasne S; Roy M; Galvez M; Rosenblatt DS
Mol Genet Metab; 2011 Apr; 102(4):494-504. PubMed ID: 21220204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
